Human phosphorylated Tau181 detection kit (Digital Immunochip Method)

Contact now

The Human p-Tau181 Protein Detection Kit (Digital Immunochip Method) by iomics Biosciences is a cutting-edge auxiliary diagnostic tool for Alzheimer’s disease. Delivering 1,000x higher sensitivity than traditional ELISA, it enables precise quantification of p-Tau181 in human plasma at femtogram levels, identifying pathological biomarkers 10-20 years before clinical symptoms manifest.

Get a Quote

Description

Phosphorylated Tau181 (p-Tau181) has emerged as a highly specific biomarker for the accurate differentiation of Alzheimer’s Disease (AD) from non-AD dementia. Our detection kit utilizes advanced single-molecule digital immunoassay technology, providing a non-invasive yet high-precision solution for clinical diagnostics and neurodegenerative research.

Key Features:

  • Revolutionary Digital Immunochip Method: Employs magnetic particles and high-resolution fluorescence amplification to quantify target proteins at ultra-low concentrations that conventional assays cannot reach.
  • Ultra-High Sensitivity: Quantifies biomarkers at the femtogram per microliter level, enabling the earliest possible detection of cognitive decline.
  • Non-Invasive Diagnostic Accuracy: Specifically optimized for human plasma samples, offering a practical alternative to painful Cerebrospinal Fluid (CSF) collection or expensive PET scans.
  • Comprehensive Clinical Utility: Essential for auxiliary AD diagnosis, monitoring neurodegeneration, and evaluating therapeutic efficacy in drug R&D.

Technical Specifications:

  • Generic Name: Human phosphorylated Tau181 protein detection kit (digital immunochip method).
  • Packing Specifications: 48 tests/box or 96 tests/box.
  • Sample Type: Human Plasma.
  • System Compatibility: Designed for the Inspirer DX Analyzer.